Rapid UTI PCR testing entered UK clinical use for the first time at the Royal Hospital Chelsea on October 28, 2026.

Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.

Medical and consumer genetics innovator Genefluence today announces the first use of its rapid, near-patient diagnostic platform to screen ...

Britain’s latest Covid 'hotspot' has been flagged in north London after figures showed 58.3% of PCR tests in Islington coming ...

Capitalize on preventive care demand through at-home testing, whole-genome sequencing and AI-powered interpretation, with North America leading adoption.Dublin, Oct. 29, 2026 (GLOBE NEWSWIRE) -- "DNA ...

ProinsulinHypoglycemiaLab Interpretation Elevated proinsulin cannot diagnose insulinoma by itself. Clinicians need a sample ...

The symptoms are largely the same as those associated with other Covid strains. According to the NHS, they include a ...

On the clinical front, AbbVie reported positive Phase 3 migraine data for QULIPTA, Genmab's petosemtamab combination improved ...

Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that ...

Dublin, Oct. (GLOBE NEWSWIRE) -- "Europe Genetic Testing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)" has been added to ResearchAndMarkets.com's offering. The ...

Portable, cartridge-based multiplex systems, digital integration, and expansion into oncology and remote care drive point-of-care molecular diagnostics adoption.Dublin, Oct. (GLOBE NEWSWIRE) -- "Point ...

Captions auto-generated & unedited.] Don't touch me with the cool of truck drivers clashing with police at the English port ...